Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
5.31
+0.21 (4.12%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $3.07 million as of August 10, 2026. Its market cap has decreased by -92.32% in one year.
Market Cap
3.07M
Enterprise Value
5.54M
1-Year Change
-92.32%
Ranking
Category
Stock Price
$5.31
ChartMarket Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $3.07M, a decrease of -97.68%. That is a compound annual growth rate of -89.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 3.07M | -91.24% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 3.97M |
| Galmed Pharmaceuticals | 3.97M |
| TransCode Therapeutics | 3.76M |
| Onconetix | 3.29M |
| 60 Degrees Pharmaceuticals | 2.98M |
| Propanc Biopharma | 2.73M |
| GRI Bio | 2.60M |
| Artelo Biosciences | 2.51M |